An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2×2 crossover designs (Q6067315)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2×2 crossover designs |
scientific article; zbMATH DE number 7766921
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2×2 crossover designs |
scientific article; zbMATH DE number 7766921 |
Statements
An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2×2 crossover designs (English)
0 references
16 November 2023
0 references
average bioequivalence (ABE)
0 references
generic drug product
0 references
significance level adjustment
0 references
two-stage adaptive designs (TSD)
0 references
type I error control (T1E)
0 references
